Annual Cash & Cash Equivalents
$91.54 M
+$65.57 M+252.41%
31 December 2023
Summary:
Amneal Pharmaceuticals annual cash & cash equivalents is currently $91.54 million, with the most recent change of +$65.57 million (+252.41%) on 31 December 2023. During the last 3 years, it has fallen by -$249.84 million (-73.18%). AMRX annual cash & cash equivalents is now -73.18% below its all-time high of $341.38 million, reached on 31 December 2020.AMRX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$74.01 M
+$30.24 M+69.08%
30 September 2024
Summary:
Amneal Pharmaceuticals quarterly cash and cash equivalents is currently $74.01 million, with the most recent change of +$30.24 million (+69.08%) on 30 September 2024. Over the past year, it has dropped by -$12.92 million (-14.87%). AMRX quarterly cash and cash equivalents is now -83.63% below its all-time high of $452.10 million, reached on 31 March 2021.AMRX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMRX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +252.4% | -14.9% |
| 3 y3 years | -73.2% | -75.5% |
| 5 y5 years | -57.1% | -65.2% |
AMRX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -73.2% | +252.4% | -75.5% | +184.9% |
| 5 y | 5 years | -73.2% | +252.4% | -83.6% | +184.9% |
| alltime | all time | -73.2% | +252.4% | -83.6% | +184.9% |
Amneal Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $74.01 M(+69.1%) |
| June 2024 | - | $43.77 M(-5.9%) |
| Mar 2024 | - | $46.52 M(-49.2%) |
| Dec 2023 | $91.54 M(+252.4%) | $91.54 M(+5.3%) |
| Sept 2023 | - | $86.93 M(-20.5%) |
| June 2023 | - | $109.28 M(-24.5%) |
| Mar 2023 | - | $144.67 M(+457.0%) |
| Dec 2022 | $25.98 M(-89.5%) | $25.98 M(-70.3%) |
| Sept 2022 | - | $87.33 M(-5.0%) |
| June 2022 | - | $91.98 M(-56.3%) |
| Mar 2022 | - | $210.48 M(-15.1%) |
| Dec 2021 | $247.79 M | $247.79 M(-18.1%) |
| Sept 2021 | - | $302.65 M(+8.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $278.31 M(-38.4%) |
| Mar 2021 | - | $452.10 M(+32.4%) |
| Dec 2020 | $341.38 M(+125.8%) | $341.38 M(+21.4%) |
| Sept 2020 | - | $281.28 M(+5.7%) |
| June 2020 | - | $266.14 M(-34.3%) |
| Mar 2020 | - | $405.24 M(+168.0%) |
| Dec 2019 | $151.20 M(-29.1%) | $151.20 M(-28.9%) |
| Sept 2019 | - | $212.74 M(+287.6%) |
| June 2019 | - | $54.89 M(-14.2%) |
| Mar 2019 | - | $63.95 M(-70.0%) |
| Dec 2018 | $213.39 M(+187.7%) | $213.39 M(+29.2%) |
| Sept 2018 | - | $165.19 M(+168.5%) |
| June 2018 | - | $61.52 M(-17.0%) |
| Dec 2017 | $74.17 M | $74.17 M |
FAQ
- What is Amneal Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Amneal Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Amneal Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of AMRX is $91.54 M
What is the all time high annual cash & cash equivalents for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual cash & cash equivalents is $341.38 M
What is Amneal Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, AMRX annual cash & cash equivalents has changed by +$65.57 M (+252.41%)
What is Amneal Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of AMRX is $74.01 M
What is the all time high quarterly cash and cash equivalents for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly cash and cash equivalents is $452.10 M
What is Amneal Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, AMRX quarterly cash and cash equivalents has changed by -$12.92 M (-14.87%)